Sort   by:  
 Page size 
UnknownAdjuvant sorafenib after heptectomy for Barcelona Clinic Liver Cancer-stage C hepatocellular carcinoma patients.
Not available
S-EPMC4910659 | biostudies-literature
UnknownEfficacy and safety of Xiangsha Liujunzi granules for functional dyspepsia: A multi-center randomized double-blind placebo-controlled clinical study.
Not available
S-EPMC5558122 | biostudies-literature
UnknownRandomized phase III trial of induction chemotherapy with docetaxel, cisplatin, and fluorouracil followed by surgery versus up-front surgery in locally advanced resectable oral squamous cell carcinoma.
Not available
S-EPMC5569675 | biostudies-literature
ProteomicsIntegrated Proteogenomic Characterization of Adenocarcinoma of the esophagogastric junction
In this study, we performed comprehensive genomic, transcriptomic, proteomic, and phosphorylation analysis of tumor tissues and paired normal adjacent tissues (NATs) of AEG. we describe integrative proteogenomic analyses of the largest cohort to date of AEG samples that focused particularly on novel...
ORGANISM(S): Homo sapiens (Human) 
2022-11-14 | PXD030725 | Pride
Adenocarcinoma of the esophagogastric junction，aeg，lc-ms/ms Proteogenomic 
ProteomicsIntegrated Proteogenomic Characterization of Adenocarcinoma of the esophagogastric junction
In this study, we performed comprehensive genomic, transcriptomic, proteomic, and phosphorylation analysis of tumor tissues and paired normal adjacent tissues (NATs) of AEG. we describe integrative proteogenomic analyses of the largest cohort to date of AEG samples that focused particularly on novel...
ORGANISM(S): Homo sapiens (Human) 
2022-11-14 | PXD030667 | Pride
Adenocarcinoma of the esophagogastric junction，aeg，lc-ms/ms Proteogenomic 
UnknownProtein degradation technology: a strategic paradigm shift in drug discovery.
Not available
S-EPMC8419833 | biostudies-literature
UnknownIntegrating multi-omics to reveal the molecular mechanism of lipid metabolism regulated by a splice variant of Lysyl-oxidase like-2, LOXL2Δ13.
Not available
S-EPMC12722292 | biostudies-literature
UnknownHigh-resolution structure of a new crystal form of BamA POTRA4-5 from Escherichia coli.
Not available
S-EPMC3144785 | biostudies-literature
UnknownStructure of the putative dihydroorotate dehydrogenase from Streptococcus mutans.
Not available
S-EPMC3034605 | biostudies-literature
ProteomicsInduced Degradation of Lineage-specific Oncoproteins Underlies the Selective PARP1 Inhibitor Toxicity in Small Cell Lung Cancer (batch2-6)
A subset of small cell lung cancer (SCLC) shows a clinical response to PARP inhibitors (PARPi) despite being proficient in homologous repair pathways. However, the underlying mechanism(s) of PARPi sensitivity is poorly understood. We performed quantitative proteomic analyses and identified proteomic...
ORGANISM(S): Homo sapiens (Human) 
2024-01-26 | PXD029968 | Pride
Quantitative proteomics Ascl1 Lineage-specific oncoproteins Synergistic effect Pips Parp1 inhibitor Predictive biomarkers A histone demethylase Brca1/2 Small cell lung cancer Homologous recombination 
Sort   by:  
 Page size